CassilethBR, ZupkisRV, Sutton-SmithK, MarchV.Information and participation preferences among cancer patients. Ann Intern Med1980; 92 (6):832–836.
2.
KleinmanA.The Illness Narratives: Suffering, Healing and the Human Condition. New York: Basic Books, 1988.
3.
MackillopWJ, O'SullivanB, WardGK. Non-small cell lung cancer: how oncologists want to be treated. Internat J Radiation Oncology-Biology-Physicians1987; 13 (6):929–934.
4.
MooreMJ, O'SullivanB, TannockIF. Are treatment strategies of urologic oncologists influenced by the opinions of their colleagues?Brit J Cancer1990; 62:988–991.
5.
BelangerD, MooreMJ, TannockIF. How American oncologists treat breast cancer: an assessment of the influence of clinical trials. J Clin Oncology1991; 9:7–16.
6.
MaherEJ, GoodmanS, JefferisA.Decision making in the management of advanced cancer of the head and neck. Differences in perspective between doctors and patients: future avenues for research. Palliative Medicine1990; 4:185–189.
7.
MackillopWJ, StewartWE, GinsburgAD, StewartSS. Cancer patients’ perceptions of their disease and its treatment. Brit J Cancer1988; 58 (3):355–358.
8.
RaghavanD.Clinician surrogates and equipoise: an analogy to lawyers who represent themselves?Europ J Cancer1991; 27 (9):1072–1074.
9.
MackillopWJ, PalmerMJ, O'SullivanB. Clinical trials in cancer: the role of surrogate patients in defining what constitutes an ethically acceptable clinical experiment. Brit J Cancer1989; 59:388–395.
10.
SimesRJ, TattersallM, CoatesAS. Randomized comparison of procedures for obtaining informed consent in clinical trials in treatment for cancer. Brit Med J1986; 293:1065–1068.
11.
MackillopWJ, WardGK, O'SullivanB.The use of expert surrogates to evaluate clinical trials in non-small cell lung cancer. Brit J of Cancer1986; 54:661–667.
12.
O'ConnorAM. Eliciting preferences for alternative drug therapies in oncology: influence of treatment outcome description, elicitation technique and treatment experience on preferences. J Chron Dis1987; 40: 811.
13.
VachonMLS. Emotional problems in palliative medicine: patient, family, professional caregivers. In: DoyleD, HanksGW, MacDonaldN (eds). The Oxford Textbook of Palliative Medicine. London: Oxford University Press (in press).
14.
SlevinML. Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and the general public. Brit Med J1990; 300:1450–1460.
15.
HadornDC. The Oregon priority-setting exercise: quality of life and public policy. Hastings Center Report1991; May–June: 11–16.
16.
McCarthyM.Hospice patients: a pilot study in twelve services. Palliative Medicine1990; 4:93–104.
17.
MacDonaldN.Role of medical and surgical oncology. In: FoleyK (ed). Advances in Pain Research and Therapy, Volume 16. New York: Raven Press1990; 27–39.
18.
PoonMA, O'ConnellHS, WieandJE, . Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer. J Clin Oncology1991; 9 (11):1967–1972.
19.
GurneyH. Ifosfamide and mitomycin in combination for the treatment of patients with progressive advanced non-small cell lung cancer. Europ J Cancer1991; 27:565–568.
20.
HardyJR, NobleT, SmithIE. Symptom relief with moderate dose chemotherapy (mitomycin-C, vinblastin and cisplatin) in advanced non-small cell lung cancer. Brit J Cancer1989; 60:764–766.
21.
MassieMJ, HollandJ, GlassE.Delirium in terminally ill cancer patients. Am J Psychiat1983; 140:1048–1050.